Secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot phase II study

被引：0
|
作者：
Olivier Cussenot
Jean-Nicolas Cornu
Sarah J. Drouin
Pierre Mozer
Christophe Egrot
Christophe Vaessen
François Haab
Marc-Olivier Bitker
Morgan Rouprêt
机构：
[1] UPMC Univ Paris 06,Institut Universitaire de Cancérologie
[2] GRC-05,Academic Department of Urology
[3] ONCOTYPE-Uro,Academic Department of Urology
[4] Pitié-Salpétrière Hospital (Assistance Publique—Hôpitaux de Paris),undefined
[5] Tenon Hospital (Assistance Publique—Hôpitaux de Paris),undefined
来源：
World Journal of Urology | 2014年 / 32卷
关键词：
PSA; Androgen deprivation therapy; Prostate cancer; Chemoprevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：545 / 550
页数：5
相关论文
共 50 条
  • [41] Association of Short-Term Patient-Reported Outcomes With Long-Term Oncologic Outcomes in Localized Prostate Cancer Patients Treated With Radiation Therapy and Androgen Deprivation Therapy in a Randomized Controlled Trial
    Roy, Soumyajit
    Spratt, Daniel E.
    Morgan, Scott C.
    Zhou, Michael
    D'Souza, Leah A.
    Drogos, Fletcher
    Malone, Julia
    Grimes, Scott
    Gualano, Christopher
    MacRae, Robert
    Mukherjee, Dibya
    Malone, Shawn
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (04): : 880 - 889
  • [42] Stereotactic Ablative Radiation and Short-Term Androgen Ablation for Intermediate-Risk Localized Prostate Adenocarcinoma: Safety and Toxicity From a Prospective Single-Arm Phase II Trial (NCT01517451)
    Phillips, R.
    Hasan, H.
    Huang, J.
    Di Pasquale, S.
    Kumar, R.
    Deek, M. P.
    Yu, C.
    DeWeese, T. L.
    Han, M.
    Gorin, M.
    Asrari, F.
    Deville, C., Jr.
    Greco, S. C.
    Song, D.
    Tran, P. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E302 - E303
  • [43] Effect of adding short-term androgen deprivation therapy to dose-escalated radiation therapy on failure-free survival for select men with intermediate-risk prostate cancer.
    Bian, Shelly
    Kuban, Deborah A.
    Levy, Lawrence B.
    Oh, Jeong Hoon
    Castle, Katherine
    Pugh, Thomas
    Choi, Seungtaek
    McGuire, Sean E.
    Frank, Steven J.
    Paul Linh Nguyen
    Lee, Andrew
    Hoffman, Karen Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [44] Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1)
    Ueno, Satoru
    Kitagawa, Yasuhide
    Onozawa, Mizuki
    Hinotsu, Shiro
    Akaza, Hideyuki
    Mizokami, Atsushi
    Namiki, Mikio
    PROSTATE INTERNATIONAL, 2018, 6 (01) : 7 - 11
  • [45] Long-Term Outcomes of Patients on a Phase II Prospective Trial of Oligometastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation and External Beam Radiation
    Hao, Claire
    Ladbury, Colton
    Lyou, Yung
    Manoukian, Saro
    Ruel, Christopher
    Frankel, Paul
    Dorff, Tanya
    Wong, Jeffrey
    Pal, Sumanta
    Twardowski, Przemyslaw
    Dandapani, Savita
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (04): : 705 - 710
  • [46] Long-Term Outcomes of Patients on a Phase II Prospective Trial of Oligometastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and External Beam Radiation
    Hao, C.
    Ladbury, C. J.
    Lyou, Y.
    Manoukian, S.
    Ruel, C.
    Frankel, P.
    Dorff, T. B.
    Wong, J. Y. C.
    Pal, S. K.
    Twardowski, P.
    Dandapani, S. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E222 - E222
  • [47] Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with 68Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer
    Otto Ettala
    Simona Malaspina
    Terhi Tuokkola
    Pauliina Luoto
    Eliisa Löyttyniemi
    Peter J. Boström
    Jukka Kemppainen
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 665 - 673
  • [48] High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial
    Zapatero, Almudena
    Guerrero, Araceli
    Maldonado, Xavier
    Alvarez, Ana
    Gonzalez San Segundo, Carmen
    Cabeza Rodriguez, Maria Angeles
    Macias, Victor
    Pedro Olive, Agusti
    Casas, Francesc
    Boladeras, Ana
    Martin de Vidales, Carmen
    Vazquez de la Torre, Maria Luisa
    Villa, Salvador
    Perez de la Haza, Aitor
    Calvo, Felipe A.
    LANCET ONCOLOGY, 2015, 16 (03): : 320 - 327
  • [49] Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial
    Krauss, Daniel J.
    Karrison, Theodore
    Martinez, Alvaro A.
    Morton, Gerard
    Yan, Di
    Bruner, Deborah Watkins
    Movsas, Benjamin
    Elshaikh, Mohamed
    Citrin, Deborah
    Hershatter, Bruce
    Michalski, Jeff M.
    Efstathiou, Jason Alexander
    Currey, Adam
    Kavadi, Vivek S.
    Cury, Fabio L.
    Lock, Michael
    Raben, Adam
    Seaward, Samantha Andrews
    El-Gayed, Ali
    Rodgers, Joseph P.
    Sandler, Howard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17) : 3203 - +
  • [50] Long-term results of a prospective phase II study of androgen deprivation therapy, external radiation, cs-131 brachytherapy, and adjuvant docetaxel in high-risk prostate cancer.
    Rice, Stephanie
    Le, Gloribel K.
    Hussain, Arif
    Mannuel, Heather Dorothy
    Naslund, Michael K.
    Amin, Pradip P.
    Kwok, Young
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345